FR3798M - Médicament a base d'un nouveau dérivé de l'anthracene. - Google Patents

Médicament a base d'un nouveau dérivé de l'anthracene.

Info

Publication number
FR3798M
FR3798M FR993214A FR993214A FR3798M FR 3798 M FR3798 M FR 3798M FR 993214 A FR993214 A FR 993214A FR 993214 A FR993214 A FR 993214A FR 3798 M FR3798 M FR 3798M
Authority
FR
France
Prior art keywords
anthracene
product based
medicinal product
new derivative
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR993214A
Other languages
English (en)
Inventor
Ernst Jucker
Anton Ebnoether
Andre Stoll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of FR3798M publication Critical patent/FR3798M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR993214A 1963-08-05 1964-10-29 Médicament a base d'un nouveau dérivé de l'anthracene. Expired FR3798M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH965163A CH433303A (de) 1963-08-05 1963-08-05 Verfahren zur Herstellung neuer carbocyclischer Verbindungen

Publications (1)

Publication Number Publication Date
FR3798M true FR3798M (fr) 1965-12-27

Family

ID=4354220

Family Applications (1)

Application Number Title Priority Date Filing Date
FR993214A Expired FR3798M (fr) 1963-08-05 1964-10-29 Médicament a base d'un nouveau dérivé de l'anthracene.

Country Status (4)

Country Link
CH (1) CH433303A (fr)
ES (1) ES302772A1 (fr)
FR (1) FR3798M (fr)
GB (1) GB1069603A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2222342B1 (fr) * 2007-11-28 2014-03-26 Nektar Therapeutics Composés tricycliques conjugués à un oligomère

Also Published As

Publication number Publication date
ES302772A1 (es) 1965-01-16
GB1069603A (en) 1967-05-17
CH433303A (de) 1967-04-15

Similar Documents

Publication Publication Date Title
FR3806M (fr) Médicament a base d'un dérivé de la quinazolone-(4).
FR3074M (fr) Médicament a base d'un nouveau dérivé hétérocyclique du benzocycloheptane.
FR3540M (fr) Médicament a base de dérivés de la 7-hydroxy-2-oxo-1.2-dihydroquinoléine.
FR3348M (fr) Médicament a base d'un nouveau dérivé de la 5.6-dihydromorphanthridine.
FR3148M (fr) Médicament a base d'un nouveau dérivé de la 5.6-dihydromorphanthridine.
FR2186M (fr) Médicament a base d'un dérivé de l'aniline.
FR3405M (fr) Médicament a base d'une sulfométhyl-polymyxine.
FR2094M (fr) Médicament a base d'un nouvel hendécapeptide.
FR3101M (fr) Médicament a base d'un nouveau composé aryl-tétralylique.
FR3680M (fr) Médicament a base d'un nouveau dérivé du thiaxanthe?
FR3798M (fr) Médicament a base d'un nouveau dérivé de l'anthracene.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR3202M (fr) Médicament a base de dérivé de théophylline.
FR3045M (fr) Médicament a base d'un nouveau dérivé de la phénothiazine.
FR3649M (fr) Médicament a base d'un nouveau dérivé de l'indole.
FR2869M (fr) Médicament a base d'un dérivé de la cymarine.
FR3778M (fr) Médicament a base d'un nouveau dérivé de thiophene.
FR3351M (fr) Médicament a base d'un nouveau dérivé de la 1.2-diphényl-3.5-dioxo-pyrazolidine.
FR3078M (fr) Médicament a base d'un nouveau polypeptide.
FR3766M (fr) Médicament a base de dérivés de naphtamidines.
FR3166M (fr) Médicament broncho-dilatateur a base d'un nouveau dérivé d'oxazolidone.
FR3301M (fr) Médicament a base d'un nouveau polypeptide.
FR2904M (fr) Médicament a base d'un nouveau polypeptide.
FR3799M (fr) Médicament a base d'un nouveau dérivé de la phénothiazine.
FR3724M (fr) Médicament a base d'anisoyl-3 hydroxy-4 p. méthoxy-phényl-6α-pyrone.